Orozco-Beltrán, Domingo
Artola, Sara
Jansà, Margarida
Lopez de la Torre-Casares, Martin
Fuster, Eva
Funding for this research was provided by:
Novartis
Article History
Received: 8 May 2017
Accepted: 6 March 2018
First Online: 23 March 2018
Ethics approval and consent to participate
: The study was conducted according to the principles of the Declaration of Helsinki and developed in compliance with Good Clinical Practice guidelines (International Conference on Harmonization, ICH, 1996). The study protocol was classified by theAgencia Española de Medicamentos y Productos Sanitarios(Spanish Agency for Medicines and Medical Devices) and was approved by the Ethics Committee of Hospital Clínic, Barcelona.All of the study participants gave their informed consent to participate in the study.
: Not Applicable.
: This study was funded by Novartis. Fuster E. works for Novartis. The remaining authors declare no conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.